Research for the Molecular Imaging of the PD-L1 Targeting Tracer
Clinical trial NCT04304066 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04304066
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-06
- Primary completion
- 2024-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.